Comments

Oculis Holding Stock Price, Quotes and Forecasts

Q: What sector and industry does Oculis Holding (OCSAW) operate in?

Oculis Holding is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

OCSAWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.95

0.435.05%

At close: -

$8.70

-0.25-2.79%

After Hours: 9:29 AM EDT

Oculis Holding (OCSAW) Forecast

News Earnings Oculis Holding (OCSAW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Oculis Holding Stock Price, Quotes and Forecasts | NASDAQ:OCSAW | Benzinga

Explore Oculis Holding stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OCSAW.

Open	$7.48
Close	$8.95
Volume / Avg.	2.00K / 3.05K
Day Range	$7.48 - $8.95
52 Wk Range	1.80 - 11.50
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$7.48
Close	$8.95
Volume / Avg.	2.00K / 3.05K
Day Range	$7.48 - $8.95
52 Wk Range	1.80 - 11.50
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

About Oculis Holding AG

Sector

Health Care

Industry

Pharmaceuticals

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improv...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Oculis Holding (OCSAW) stock?

You can purchase shares of Oculis Holding (NASDAQ:OCSAW) through any online brokerage.

View our list of the best stock brokerages

Who are Oculis Holding (OCSAW) competitors?

Other companies in Oculis Holding’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Oculis Holding (OCSAW) stock?

There is no analysis for Oculis Holding to provide a consensus price target.

What is the current price for Oculis Holding (OCSAW)?

The stock price for Oculis Holding (NASDAQ: OCSAW) is $7.48 last updated May 22, 2025 at 10:43 AM EDT.

Does Oculis Holding (OCSAW) pay a dividend?

There are no upcoming dividends for Oculis Holding.

When is Oculis Holding (NASDAQ:OCSAW) reporting earnings?

Oculis Holding does not have any upcoming earnings scheduled.

Is Oculis Holding (OCSAW) going to split?

There is no upcoming split for Oculis Holding.

What sector and industry does Oculis Holding (OCSAW) operate in?

Oculis Holding is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.